Left ventricular reduction for idiopathic dilated cardiomyopathy as alternative to transplant--truth or dare?

T Doenst1, L Ahn-Veelken, C Schlensak

  • 1Department of Cardiovascular Surgery, University of Freiburg, Freiburg i. Br., Germany. doenst@ch11.ukl.uni-freiburg.de

Insights

Left ventricular reduction surgery offers immediate cardiac function improvement in dilated cardiomyopathy (DCM) patients. However, long-term benefits remain uncertain, making it an option only for those unsuitable for heart transplantation.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • The efficacy of left ventricular reduction surgery for advanced heart failure, specifically idiopathic dilated cardiomyopathy (DCM), remains debated due to conflicting clinical data.
  • While surgery aims to reduce wall tension, the underlying causes of dilation and contractile dysfunction in DCM may limit its long-term benefits.
  • The natural progression of dilated cardiomyopathy can potentially overshadow the advantages gained from surgical interventions.

Purpose of the Study:

  • To evaluate the outcomes of a modified Dor's endoventricular patch plasty for restoring physiological geometry in patients with dilated cardiomyopathy.
  • To assess the immediate and long-term effects of left ventricular reduction surgery on cardiac function in DCM patients.

Main Methods:

  • A series of five patients with dilated cardiomyopathy underwent left ventricular reduction surgery using a modified endoventricular patch plasty.
  • Cardiac function was assessed immediately post-operation and monitored during follow-up periods up to 18 months.

Main Results:

  • All five patients experienced immediate improvement in cardiac function following the procedure.
  • One patient maintained improved function at 18 months, while another required heart transplantation due to ventricular arrhythmias.
  • Two patients experienced recurrence of left ventricular dilation and were listed for transplantation; one patient died from sepsis.

Conclusions:

  • The modified endoventricular patch plasty is generally well-tolerated in DCM patients, providing initial contractile function improvement.
  • The long-term efficacy of this surgical technique for dilated cardiomyopathy is uncertain, and it is not currently a substitute for heart transplantation.
  • This procedure may be a viable option for select DCM patients who have contraindications for heart transplantation.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...